Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 3, 1998, Pages 239-244

  Phillips, Andrew N ^a   Katlama, Christine ^c   Barton, Simon ^b   Vella, Stefano ^d   Blaxhult, Anders ^e   Clotet, Bonaventura ^f   Goebel, Frank Detlef ^g   Hirschel, B ^h   Pedersen, Court ⁱ   Lundgren, Jens D ⁱ  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b St Stephens Clinic   (United Kingdom)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e DANDERYD HOSPITAL   (Sweden)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

ⁱ HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Antiretroviral drugs; Nucleoside analogues; Survival; Zidovudine

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NUCLEOSIDE ANALOG; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EUROPE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 13144261683     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199803010-00009     Document Type: Article

References (14)

1. Corey L, Holmes KK. Therapy for human immunodeficiency virus infection - what have we learned? N Engl J Med 1996;335: 1142-4.
2. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. JAMA 1996;276:146-54.
3. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-90.
4. Delta Coordinating Committee. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996;348:283-91.
5. Graham NMH, Hoover DR, Park LP, et al. Survival in HIV-infected patients who have received zidovudine: comparison of combination therpay with sequential monotherapy and continued zidovudine monotherapy. Ann Intern Med 1996;124:1031-8.
6. Lundgren JD, Phillips AN, Vella S, et al. Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. J Acquir Immune Defic Syndr 1997; 16:153-60.
7. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
8. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
9. Saravolatz LD, Winslow DL, Collins G, et al. Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. N Engl J Med 1996;335:1099-106.
10. CAESAR Coordinating Committee. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. Lancet 1997;349:1413-21.
11. Miettinen OS. The need for randomization in the study of intended effects. Stat Med 1983;2:267-71.
12. Gail MH. Use of observational data, including surveillance studies, for evaluating AIDS therapies. Stat Med 1996;15:2273-88.
13. Glesby MJ, Hoover DR. Survivor treatment selection bias in observational studies: examples from the AIDS literature. Ann Intern Med 1996;124:999-1005.
14. Lundgren JD, Phillips AN, Pedersen C, for the AIDS in Europe Study Group. Comparison of long term prognosis of patients with AIDS treated and not treated with zidovudine. JAMA 1994;271: 1088-92.